Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.

Registrieren

XBIT XBiotech Inc

4,17

0,00 (0,00%)

Vor Marktöffnung

Zuletzt aktualisiert: 12:17:13

Verzögert um 15 Minuten

Annual Report to Security Holders (ars)

This regulatory filing also includes additional resources:
d453261dars.pdf

XBiotech (NASDAQ:XBIT)
Historical Stock Chart
Von Dez 2024 bis Jan 2025

Click Here for more XBiotech Charts.

XBiotech (NASDAQ:XBIT)
Historical Stock Chart
Von Jan 2024 bis Jan 2025

Click Here for more XBiotech Charts.

News Xbiotech Inc.

Form 8-K - Current report
Dienstag 31 Dezember 2024 (3 Tage vor) • Edgar (US Regulatory)

XBiotech Pauses Rheumatology program
Montag 23 Dezember 2024 (2 Wochen vor) • GlobeNewswire Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Mittwoch 13 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Montag 12 August 2024 (5 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Donnerstag 20 Juni 2024 (6 Monate vor) • Edgar (US Regulatory)

XBiotech Results from Randomized Double-Blinded Phase 1/2 Study Suggest Potential Breakthrough Treatment for Advanced Pancreatic Cancer
Dienstag 18 Juni 2024 (7 Monate vor) • GlobeNewswire Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Freitag 10 Mai 2024 (8 Monate vor) • Edgar (US Regulatory)

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Mittwoch 7 Februar 2024 (11 Monate vor) • Edgar (US Regulatory)

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Mittwoch 7 Februar 2024 (11 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Freitag 5 Januar 2024 (12 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Donnerstag 4 Januar 2024 (12 Monate vor) • Edgar (US Regulatory)

XBiotech to Begin Constructing New R&D Facility on its 48-acre Campus
Donnerstag 4 Januar 2024 (12 Monate vor) • GlobeNewswire Inc.

Weitere Xbiotech Inc. News-Artikel

Deutsche Telekom

Energy Select Sector SPDR

Health Care Select Sector

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen